BioCentury
ARTICLE | Financial News

Juno Therapeutics amends IPO

December 15, 2014 8:00 AM UTC

Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Date announced: 2014-12-09 Type: IPO To be raised: Up to $166.5 million Shares: 9.3 million Price: $15-$18 Underwriters: Morgan Stanley; JPMorga...